Hospitals & Healthcare Pressreleases

This section covers the managerial aspects in the Healthcare industry.

PacBio’s SMRT Sequencing Provides Scientists with a Superior Gorilla Genome Reference

Thursday, March 31, 2016
GLOBE NEWSWIRE

MENLO PARK Calif March 31 2016 GLOBE NEWSWIRE Pacific Biosciences of California Inc NasdaqPACB the pioneer and leader in longread sequencing using its Single Molecule RealTime SMRT technology today announced that scientists from the University of Washington the McDonnell Genome Institute at Wa..

Celator® Pharmaceuticals Announces New Data for VYXEOS™ in FLT3-ITD Mutated AML Cells Derived from Patients with Newly Diagnosed AML to be Presented at the American Association for Cancer Research Annual Meeting

Thursday, March 31, 2016
PR Newswire

EWING NJ March 31 2016 PRNewswire Celator Pharmaceuticals Inc Nasdaq CPXX today announced that data for VYXEOS cytarabinedaunorubicin Liposome for Injection also known as CPX351 its lead product candidate will be presented at the American Association for Cancer Research AACR Annual Meeting in New ..

Medical Marijuana, Inc.’s HempMeds® Mexico Sponsors Cross-Border Forum, U.S. Representatives and Mexican Political Candidates Set to Discuss Rights to Patient Access

Thursday, March 31, 2016
GLOBE NEWSWIRE

SAN DIEGO March 31 2016 GLOBE NEWSWIRE Medical Marijuana Inc OTC PINKMJNA is proud to announce to shareholders and the public that portfolio company HempMeds Mexico is sponsoring a crossborder effort to discuss new perspectives on cannabis and legal access in Mexico Former California Assembl..

RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Dermal Indications

Thursday, March 31, 2016
PR Newswire

MARLBOROUGH Mass March 31 2016 PRNewswire RXi Pharmaceuticals Corporation NASDAQ RXII a clinicalstage RNAi company developing innovative therapeutics in dermatology and ophthalmology that address significant unmet medical needs announced today that it has received an Issue Notification from the U..

Celimmune Commences Screening in Phase 2 Clinical Study in Refractory Celiac Disease Type II

Thursday, March 31, 2016
PR Newswire

LEBANON NJ and BETHESDA Md March 31 2016 PRNewswire Celimmune LLC a clinical developmentstage immunotherapy company focused on treating and preventing immunemediated diseases announced that it has commenced screening patients in its Phase 2 clinical study for AMG 714 an investigational antiIL15 mo..

ANSYS Introduces Industry\'s Most Comprehensive Pay-Per-Use Licensing Model For Engineering Simulation Software

Thursday, March 31, 2016
PR Newswire

PITTSBURGH March 31 2016 PRNewswire Companies around the world now have unprecedented flexibility to solve the toughest engineering and product challenges thanks to the introduction of ANSYS Elastic Licensing This new ANSYS NASDAQ ANSS payperuse licensing model unlocks the worlds br..

EQUASHIELD Wins 2016 Red Dot Award for Medical Product Design

Thursday, March 31, 2016
PR Newswire

PORT WASHINGTON New York March 31 2016 PRNewswire Equashield a leading provider of Closed System Transfer Devices CSTDs for safe and simple handling of hazardous drugs today announced that EQUASHIELD was named a 2016 Red Dot Award winner Participants from 57 nations submitted more than 5000 prod..

PLT Launches Water-Soluble Form of Industry-Leading 5-LOXIN® Joint Health Ingredient

Thursday, March 31, 2016
PR Newswire

MORRISTOWN NJ March 31 2016 PRNewswire PLT Health Solutions Inc announced the introduction of a watersoluble version of the companys bestselling 5LOXIN for joint health support Called AquaLOX the new ingredient is a potent Boswellia serrata extract documented to have a similar pharmacokinetic prof..

Medical Ceramics Market will Reach $2.2 billion in 2021 according to New Report from n-tech Research

Thursday, March 31, 2016
PR Newswire

GLEN ALLEN Va March 31 2016 PRNewswire According to a new report from industry analyst firm ntech Research the global market for medical ceramic will grow to around 22 billion in revenue in 2021 The report titled Worldwide Medical Ceramic Markets 20162025 identifies the current and future opportu..

The ALS Association Awards Origent Data Sciences a Grant to Enable a Research Partnership with Cytokinetics

Thursday, March 31, 2016
PR Newswire

WASHINGTON March 31 2016 PRNewswireUSNewswire Today The ALS Association is pleased to announce the awarding of an ALS AssociationInitiated Grant to David Ennist PhD MBA Chief Scientific Officer of Origent Data Sciences Inc based in Vienna VA for 497433 over 34 months that will enable a research pa..

Ionis Pharmaceuticals Advances Nusinersen in the Ongoing SHINE Study in Patients with SMA

Thursday, March 31, 2016
PR Newswire

CARLSBAD Calif March 31 2016 PRNewswire Ionis Pharmaceuticals Inc NASDAQ IONS announced today that it has earned a milestone payment of 75 million from Biogen for advancing nusinersen in the openlabel extension study SHINEThe SHINE study was initiated in October 2015 to provide nusinersen to infa..

Genomics Firm Nabsys Completes Financial Restructuring and Reinstates Technical Leadership Team

Thursday, March 31, 2016
PR Newswire

PROVIDENCE RI March 31 2016 PRNewswire Genomics firm Nabsys has completed a financial restructuring under the leadership of founding CEO Barrett Bready MD who returned to the company in October 2015 In addition members of the original technical leadership team including Chief Technology Officer Jo..

Harvard Apparatus Regenerative Technology Changes Name to Biostage, Inc. (NASDAQ: BSTG)

Thursday, March 31, 2016
PR Newswire

HOLLISTON Mass March 31 2016 PRNewswire Harvard Apparatus Regenerative Technology Inc NASDAQ HART announced today it has changed its corporate name to Biostage Inc and will trade under the Nasdaq symbol BSTG effective April 1 2016 Concurrently the company has launched a new web site wwwbiostagecom..

Super Supplements® Hosts Event to Celebrate Healthy Living on April 2

Thursday, March 31, 2016
PR Newswire

SECAUCUS NJ March 31 2016 PRNewswire Join Super Supplements on Saturday April 2 for a special event to get ready for a healthy spring All Super Supplements stores will host a Share the Health Expo from 11am 2pm local time The Expo will offer shoppers wellness tips and seasonal product recommendat..

Oxis Praises Biden\'s \'Cancer Moonshot,\' Says its Portfolio of Targeted Immunotherapies Provides Next-Generation Cancer Treatments

Thursday, March 31, 2016
PR Newswire

LOS ANGELES March 31 2016 PRNewswire Oxis Biotech Inc a wholly owned subsidiary of Oxis International Inc OTC OXIS and Euronext Paris OXIPA expressed its support of the cancer moonshot which seeks to incentivize cooperation between the government and the private sector in the development of new tr..

Cardiome Announces Publication of Independent Study Comparing BRINAVESS to Ibutilide in Patients with Recent-Onset Atrial Fibrillation

Thursday, March 31, 2016
PR Newswire

NASDAQ CRME TSX COM VANCOUVER March 31 2016 PRNewswire Cardiome Pharma Corp NASDAQ CRME TSX COM today announced the publication of results from an open label singlecenter randomized controlled study conducted by independent researchers at the Medical University of Vienna in Vienna Austria It ..

Iroko Pharmaceuticals to Present Phase 3 VIVLODEX® Efficacy and Safety Data at World Congress of Osteoarthritis

Thursday, March 31, 2016
PR Newswire

PHILADELPHIA March 31 2016 PRNewswire Iroko Pharmaceuticals LLC a global specialty pharmaceutical company dedicated to advancing the science of analgesia announced today that it will present two new analyses of data from the VIVLODEX meloxicam capsules Phase 3 program This includes an analysis fro..

Health2047 Expands Advisory Board with New Strategic Appointments

Thursday, March 31, 2016
PR Newswire

SAN FRANCISCO March31 2016 PRNewswire Health2047 the integrated innovation company purposebuilt to improve US healthcare today announced the appointment of enterprise technology and investment experts Charles Aunger and Tom Frederick to its industry advisory board These two industry veterans will ..

Aytu BioScience Awarded Health Canada Approval for Its MiOXSYS™ System for Male Infertility

Thursday, March 31, 2016
PR Newswire

ENGLEWOOD Colo March 31 2016 PRNewswire Aytu BioScience Inc OTCQX AYTU a commercialstage specialty healthcare company focused on global commercialization of novel products in the field of urology has obtained Health Canada Class II Medical Device approval for its MiOXSYS SystemMiOXSYS is the comp..

Cardinal Health to Release Third-Quarter Results for Fiscal Year 2016 on April 28

Thursday, March 31, 2016
PR Newswire

DUBLIN Ohio March 31 2016 PRNewswire Cardinal Health plans to release thirdquarter financial results for its fiscal year 2016 on April 28 prior to the opening of trading on the New York Stock Exchange The company has scheduled a webcast and conference call for April 28 at 830 am Eastern to discus..

TOP